| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.018 | 0.9 |